42 filings · most recent first
JAZZ 8-K Filings
Jazz Pharmaceuticals Completes Acquisition Of Actio Biosciences
Jazz Pharmaceuticals Announces 125 Billion Notes Issuance And Share Repurchase
Fda Approves Jazz Pharmaceuticals Ziihera For Firstline Treatment Of Her2
Jazz Pharmaceuticals Shareholders Approve Key Proposals At 2026 Agm
Anne Oriordan To Depart From Jazz Pharmaceuticals Board
Jazz Pharmaceuticals Reports 16 Yoy Revenue Growth And Raises 2026 Guidance
Jazz Pharmaceuticals Reports Strong Q1 2026 Financial Results With 19 Revenue
Jazz Pharmaceuticals Reports 2025 Financial Results And Provides 2026 Guidance
Jazz Pharmaceuticals Announces Merger With Actio Biosciences
Jazz Pharmaceuticals To Acquire Actio Biosciences For 820 Million Upfront
Jazz Pharmaceuticals Provides Financial Update And Guidance At Jp Morgan
Jazz Pharmaceuticals Appoints New Director And Announces Retirement Of Board
Jazz Pharmaceuticals Reports Third Quarter 2025 Financial Results And Updates
Jazz Pharmaceuticals Announces Q2 2025 Financial Results And Updates Guidance
Jazz Pharmaceuticals Shareholder Approvals At 2025 Annual General Meeting
Jazz Pharmaceuticals Reports Q1 2025 Results And Updates Guidance
Jazz Pharmaceuticals Reports Strong 2024 Financial Results And Provides 2025
Jazz Pharmaceuticals Announces Strong Q3 2024 Financial Results
Jazz Pharmaceuticals To Terminate Existing Lease And Sign New One
Jazz Pharmaceuticals Reports Strong Q2 2024 Financial Results And Updates
Jazz Pharmaceuticals Shareholders Approve All Proposals At 2024 Annual Meeting
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results And Affirms
Jazz Pharmaceuticals Reports Strong 2023 Financial Results And Provides 2024
Jazz Pharmaceuticals Announces Positive Phase 3 Results For Ziihera In Her2
Jazz Pharmaceuticals Settles Patent Disputes With Avadel
Jazz Pharmaceuticals Appoints Renee Gala As New Ceo
Jazz Pharmaceuticals Completes Acquisition Of Chimerix
Jazz Pharmaceuticals Announces Preliminary Settlement Agreement For 145 Million
Jazz Pharmaceuticals Corrects Typographical Error In Merger Agreement
Jazz Pharmaceuticals To Acquire Chimerix For 935 Million
Jazz Pharmaceuticals Expects To Meet 2024 Revenue Guidance
Jazz Pharmaceuticals Ceo To Retire
Jazz Pharmaceuticals Extends And Increases Revolving Credit Facility
Jazz Pharmaceuticals Receives Fda Approval For Ziihera To Treat Her2Positive
Jazz Pharmaceuticals Announces 10B Exchangeable Senior Notes Offering And
Jazz Pharmaceuticals Secures Partial Injunction Against Avadel Pharmaceuticals
Jazz Pharmaceuticals Announces Amendment To Credit Agreement For Us Dollar Term
Dr Catherine Sohn Retires From Jazz Pharmaceuticals Board
Jazz Pharmaceuticals Appoints New Board Member And Announces Departure Of
Jazz Pharmaceuticals Appoints New Chief Financial Officer
Jazz Pharmaceuticals Reprices Us Dollar Term Loans
Jazz Pharmaceuticals Updates 2024 Growth Outlook